Haga Clic en esta casilla

Haga Clic en el Título

Vea artículo No. 1

1.     *Allen J, Ferneley D, Seawood L, Coster J, Milmow S, Culverwell EA.  The Clave Needleless System. Clinical Hematology Unit-Bone Marrow Transplant Unit-Christchurch Hospital, Christchurch, New Zealand. 1995.

Vea artículo No. 2

2.     *Brown JD, Moss HA, Elliot TSJ.  The Potential for Catheter Microbial Contamination from a Needleless Connector, The Hospital Infection Society, pgs.181-189, 1997

Vea artículo No. 3

3.     *Camp-Sorrell D, Beschorner J, Caudell KA, et al. Access Device Guidelines: Recommendations for Nursing Practice and Education.  Oncology Nurcing Society. 1-83, October 1996.

Vea artículo No. 4

4.     Cooksong ST, Ihrig M, O’Mara E, Denny M, Volk H, Banerjee SM, Harstein A, Jarvis W Increased Bloodstream Infection Rates in Surgical Patients Associated With Variation from Recommended Use and Care Following Implementation of a  Needleless Device, Infection Control and Hospital Epidemiology, Vol.19, No.1 Pg. 23-27, January 1998.

Vea artículo No. 5

5.     Danzing LE, Short LJ, Colling K, et al. Blood Stream Infections Associated with* A Needleless Intravenous Infusion System in Patients Receiving Home Infusion Therapy. JAMA, V.273, #23m pgs 1862-1864, 1995

Vea artículo No. 6

6.     *Edmond M, Khakoo R, McTaggart B, Solomon R. Effect of Bedside Needle Disposal Units on Needle Recapping Frequency and Needlestick Injury. Infection Control-Hospital Epidemiology, V.9, #3, pgs.114-116, 1988

Vea artículo No. 7

7.     *Eckrich HM. Latex Allergy. Nursing Education Lovelace Health Systems, Albaquerque, New Mexico. Pgs 1-15, 1995

Vea artículo No. 8

8.     Geberding JL. Incidence and Prevalence of HIV Virus, Hepatitis B Virus, Hepatitis C Virus, and CMV among Health Care Professionals at Risk for Blood Exposure: Final Report from a Longitudinal Study. Journal of Infectious Diseases, V.170,pgs.1410-1417, 1994.

Vea artículo No. 9

9.     Gibilisco PA, Lopez GA, Appleman MD, et al. In Vitro Contamination of “Piggyback/Heparin Lock” Assemblies: Prevention of Contamination with a Closed, Positive Locking Device (Click-Lock). JPEN , V.10, #4, 431-434, 1986

Vea artículo No. 10

10.  Gibilisco PA, Miller JS, Holt DC.  Contamination of the Clave Connector: Effective Decontamination Using 70% Isopropyl Alcohol.  Silliker Labs of  California, June 1992

Vea artículo No. 11

11.  Gibilisco PA, Page GS. Experimental Microbial Challenge and Decontamination of Clave Connectors.  Contract Quality Assurance GLP-GMP Microbiology Labs, Laboratory Services, Monravia, California, 1993

Vea artículo No. 12

12.  Gibilico PA, Magnifico M. Mock Transfusion of 500CC of Whole Blood Using Using an 18 Gauge Needle vs a Clave Connector: No Hemolysis Ocurred Using Either Device.  Northwest Connecticut Oncology Associates, Torrington, Connecticut, 1994

Vea artículo No. 13

13.  Keller CA. Methods of Drawing Blood Samples Through Central venous Catheters in Pediatric Patients Undergoing Bone Marrow Transplant: Results of a National Survey.  Oncology Nurses Forum, V.21, #5,pgs.879-884, 1994

Vea artículo No. 14

14.  Krasinski K, LaCouture R, Holtsman RS. Effect of Changing Needle Disposal Systems on Needle Puncture Injuries.  Infection Control, V.8, #2,pgs.59-62, 1987

Vea artículo No. 15

15.  Lanpher BD, Linkerman CC, Cannon CG, et al, Hepatitis C virus Infection on Health Care Workers : Risk of Exposure and Infection.  Infection Control, Hopital Epidemiology. V.15. 745-750, 1994

Vea artículo No. 16

16.  *Larson E.  APIC Guidelines For Infection Control Practice: Guideline for Use of Topical Antimicrobial Agents. America Journal of Infection Control. V.16,#6, pgs 253-265,December, 1988,

Vea artículo No. 17

17.  MacGeorge L, Steeves L, Steeves RH. Comparison of the Mixing and reinfusion Methods of Drawing Blood From a Hickman® Catheter.  Oncology Nurses Forum, V.15, #3, pgs.335-338,1988

Vea artículo No. 18

18.  *Magnifico M, Gibilisco PA. Mock Transfusion of Packed red blood Cells Using an 18 Gauge Needle vs a Clave™ Connector: No Hemolysis Occurred Using Either Device. Northwest Connecticut Oncology Associates, Torrington, Connecticut, 1994

Vea artículo No. 19

19.  Maxwell K, Hudson K,Leeah M, LaFave D, Use of Flush Bags for home Infusion Patients, Scott & White Infusion Services, Temple TX

Vea artículo No. 20

20.  *Pearson ML, et al. Guideline For Prevention of Intravascular Device-Related Infections. AJIC Vol 24, #4, pgs.262-293, 1996 (CDC Guidelines).

Vea artículo No. 21

21.  * Ruschman KL, Fulton J, Effectiveness of Disinfectant Techniques on Intravenous Tubing Latex Injection Ports. Journal of Intravenous Nursing, V.16, #5, pgs.304-308, Sept./October 1993.

Vea artículo No. 22

22.  *Walrath JM, Abbott NK, Caplan E et al, Stopcock: Bacterial Contamination in Invasive Monitoring Systems. Heart and Lung, V8, #1, 100-104, 1979

Vea artículo No. 23

23.  Lipman CT, Redding JS. Letter to the Editor Re: “Catheter-Acquired Infections and Role of Stopcock contamination”. Hearth and Lung:Vol.13, No.4,1984.

Vea artículo No. 24

24.  Federal Register.Potential Sources for Contamination of Intravascular Devices. Notices; Figure 1, September 27, 1995.

Vea artículo No. 25

25.  Prince K, Summer L, Knight MA.  Needleless IV Therapy: Comparing Three Systems for Safety. Nursing Management :Vol.25, No. 3, March, 1994.

Vea artículo No. 26

26.  Murray G. Evaluating Needle-free Systems. The Irish Pharmacy Journal:October, 1997.

Vea artículo No. 27

27.  Lenhart C. Clinical Critique: New Hope for Managing Occlusions of CVDs (Central Veneous Access Devices). “League of Intravenous Therapy Education”: Spectrum: Vol. 11, No. 3, July, 1999.

Vea artículo No. 28

28.  Gabriel J. What is the Actual Price of an Occluded Venous Catheter? Presented in the NAVAN Conference,San Diego, CA. USA,Sept.,1999. Publication in Progress.

Vea artículo No. 29

29.  Lenhart C. Prevention vs. Treatment of Venous Access Device Occlusions. Western Pennsylvania Hospital,Pittsburg, Pennsylvania, 1999.

Vea artículo No. 30

30.  Wyckoff MM. CLC-2000 Use and Lack of Clotting in Venous Catheter. Testimonial Letter, June 3,1999.

Vea artículo No. 31

31.  Nakazawa-Carpol  N. Prevention of Clots in Peripherally Inserted Central Catheters(PICC) Lines Using the CLC 2000. University California San Francisco, Stanford,  CA. USA, June 2,1999. A Testimonial.

Vea artículo No. 32

32.  Mac Pherson J. The Interlink Needless System Did not Reduce the Number of  Needlestick Injuries in Christchurch Hospital Operating Theaters.  New Zealand Medical Journal, October 11, 1996,Pages 387-388.

Vea artículo No. 33

33.  L’Ecuyer PB, Owens Schwab E, Iadermarco E, ET AL. Randomized Prospective Study of three Needless Intravenous Systems on Neddlestick Injury Rates. Infection Control and Hospital Epidemiology:Vol. 17, No. 12, 803-808, 1996.

Vea artículo No. 34

34.  Gartner K. Impact of a Needleless Intravenous System in a University Hospital. AJIC: Vol. 20, No. 2, 1992.

Vea artículo No. 35

35.  Horner, KA.  Technology Assessment of Two Needleless Systems. Journal of Intravenous Nursing: Vol. 21, No. 4, 203-207. 1998.

Vea artículo No. 36

36.  Gilibisco P, Lindenberg RL, Polito W, ET AL. The Lopez Enteral Valve: a Protective Device for Administering Medications Via Nasogastric TuBe in Critically I11 Patients. Gastroenterology and Endoscopy News, pp.12-13, September 1986.

Vea artículo No. 37

37.  Zimmaro Bliss D, Dysart M. Using Needless Intravenous Access Devices for Administering Total Parenteral Nutrition (TPN): Practice Update. Nutrition in Clinical Practice: Vol. 14: 299-303. 1999.

Vea artículo No. 38

38.  Ferran JE. Estudio Comparativo Entre Dos Metodos De Proteccion De La Llave De Tres Pasos En Los Cateteres Arteriales. Unidad de Vigilancia Intensiva, Hospital Cruz Roja de Barcelona, Barcelona, Spain. March, 2000.

Vea artículo No. 39

39.  Ihrig M, Cookson ST, Campbell K, ET AL. Evaluation of the Acceptability of a Needleless Vascular-Access system by Nurses.AJIC: Vol.25, No.5, 434-438. 1997.

Vea artículo No. 40

40.  Savino SR, Napolitano MA. A Comparison  Between Two Intermittent  Intravenous Systems Without Needles. Journal of Intravenous Nursing:Vol.17 No. 5,256-260. 1994.

Vea artículo No. 41

41.  Orenstein R, Reynolds L, Karabic M, et AL. Do Protective Devices Prevent Needlestick Injuries Among Health Care Workers? AJIC: Vol.23, No. 6, 344-351. 1995.

Vea artículo No. 42

42.  McDonald,LC, Banerjee SM, Jarvis WR. Line-Associated Bloodstream Infection In Pediatric Intensive-Care-Unit Patients Associated With a Needleless Device and Intermittent Intravenous Therapy. Infection Control and Hospital Epidemiology: Vol. 19, No. 10, 772-777. 1998.

Vea artículo No. 43

43.  Lawrence LW, Declos GL, Felknor SA,et AL. The Effectiveness of a Needleless Intravenous connection System: An Assessment By Injury Rate and User Satisfaction. Infection Control and Hospital Epidemiology: Vol.18, No. 3,  175-182. 1997.

Vea artículo No. 44

44.  Gibilisco PA. Protezione degli Operatori e dei Pazienti Durante L’uso dei Cateteri Venosi. Congresso Rianinazine, Opedale Careggi, Firenze, Italy, 1998.

Vea artículo No. 45

45.  Lucet JC, Hayon J, Bruneel F, et AL. Microbiological Evaluation of Central Venous Catheter Administration Hubs. Infection Control and Hospital Epidemiology:Vol.21, No. 1, 40-42. 2000.

Vea artículo No. 46

46.  Sitges-Serra A, Puig P, Linares J. Et al : Hub Colonization as the Initial Step in An Outbreak of Catheter Related Sepsis due to Coagulase Negative Staphilococci During Parenteral Nutrition. JPEN, 8:668-672, 1984.

Vea artículo No. 47

47.  Chodoff A, Pettis AM, Schoonmaker D, Shelly MA, Polymicrobial gram-Negative bacterimia with saline solution flush used with a needless intravenous system, American Journal of Infection Control, pp.357-363, December 1995.

Vea artículo No. 48

48.  Oie  S, Kamiya A, Mircrobial contamination of antiseptics and disinfectants, American Journal of Infectious Control, pp. 389-395, October 1996.

Vea artículo No. 49

49.  Extended Use Microbial Challenge and Disinfection Study of the Clave® Connector.  ICU Medical, Inc, San Clemente, California.

Vea artículo No. 50

50.  Maki DG, Ringer M, Alvarado CJ,  Prospective randomized trial of providone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters,  The Lancet, Vol. 338, August 10,1991. pp.339-343.

Vea artículo No. 51

51.  MedNews MedCare Medical Group, Inc. 234 Old Homestead Hwy., Swanzey NH,  03446,  November 1997 Huber Loc™   Huber Needle Removal And Containement Device Issue 1.